A randomized phase II multicenter trial to explore efficacy of weekly intraperitoneal in comparison with intravenous paclitaxel administered immediately after gastrectomy to the patients with high risk of peritoneal recurrence: final results of the INPACT trial

被引：0
|
作者：
Naoto Takahashi
Mitsuro Kanda
Takaki Yoshikawa
Nobuhiro Takiguchi
Kazumasa Fujitani
Katsufumi Miyamoto
Yuichi Ito
Osamu Takayama
Motohiro Imano
Norio Mitsumori
Junichi Sakamoto
Satoshi Morita
Yasuhiro Kodera
机构：
[1] Kashiwa Hospital,Department of Surgery, Jikei University School of Medicine
[2] Nagoya University Graduate School of Medicine,Department of Gastroenterological Surgery (Surgery II)
[3] Kanagawa Cancer Center,Department of Gastrointestinal Surgery
[4] Chiba Cancer Center,Division of Gastroenterological Surgery
[5] Osaka Prefectural General Medical Center,Department of Surgery
[6] Hyogo Prefectural Awaji Medical Center,Department of Surgery
[7] Aichi Cancer Center Hospital,Department of Gastroenterological Surgery
[8] Itami City Hospital,Department of Surgery
[9] Kinki University,Department of Surgery, Faculty of Medicine
[10] Jikei University School of Medicine,Department of Surgery
[11] Tokai Central Hospital,Department of Biomedical Statistics and Bioinformatics
[12] Kyoto University Graduate School of Medicine,undefined
来源：
Gastric Cancer | 2018年 / 21卷
关键词：
Gastric cancer; Intraperitoneal administration; Paclitaxel; Peritoneal metastasis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1014 / 1023
页数：9
相关论文
共 43 条
  • [41] Randomized phase II trial of modified (m) FOLFOX6 induction chemotherapy with or without aflibercept before standard chemoradiotherapy (CRT) and total mesorectal excision (TME) in patients with high-risk rectal adenocarcinoma (HRRC): Final results of the GEMCAD 1402, and by molecular subtypes.
    Fernandez-Martos, Carlos
    Machado, Isidro
    Pericay, Carles
    Salas, Nuria
    Batlle, Jaime Feliu
    ten Hoorn, Sanne
    Vermeulen, Louis
    Losa, Ferran
    Carbonero, Rocio Garcia
    Alonso, Vicente
    Vera, Ruth
    Gallego, Javier
    Capdevila, Jaume
    Salud, Antonieta
    Nogu, Miguel
    Maurel, Joan
    Layos, Laura
    Montagut, Clara
    Garcia-Albeniz, Xabier
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] Final Results of a Phase II Danish Trial Testing Low Dose Total Body Irradiation Following Six Bi-Weekly RCHOP-14 Plus 2 Extra Rituximab in Elderly High risk Patients with Aggressive CD20+Diffuse Large B-Cell Lymphoma (DLBCL).
    Safwat, Akmal
    Specht, Lena
    Hansen, Flemming
    Hansen, Mads
    Jurlander, Jesper
    d'Amore, Francesco
    BLOOD, 2008, 112 (11) : 372 - 373
  • [43] Quality of life results from OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)-adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER-2 negative early breast cancer
    Ganz, Patricia A.
    Bandos, Hanna
    Spanic, Tanja
    Friedman, Sue
    Muller, Volkmar
    Kummel, Sherko
    Delaloge, Suzette
    Brain, Etienne
    Toi, Masakazu
    Yamauchi, Hideko
    de Duenas, Eduardo-Martinez
    Armstrong, Anne
    Im, Seock-Ah
    Song, Chuangui
    Zheng, Hong
    Sarosiek, Tomasz
    Sharma, Priyanka
    Rossi, Giovanna
    Rastogi, Priya
    Fielding, Anitra
    Gelber, Richard D.
    Campbell, Christine
    Garber, Judy E.
    Geyer, Charles E., Jr.
    Tutt, Andrew N. J.
    CANCER RESEARCH, 2022, 82 (04)
12345